Equity Strategy
21 May 2025
Out of Cycle Reporting Update
ASX 200 EPS Forecasts Have Been Downgraded Since the Start of April
 

There have been out of season results over the past month, which in conjunction with global macro developments have seen aggregate ASX 200 EPS forecasts for FY26 lowered. 

After results from the Big 4 Banks and industrials, operational updates in the resources sectors, as well as ‘Liberation Day’ tariffs (which have been partially walked back), the ASX 200 is now expected to deliver EPS growth of 6% in FY26. This is down from forecasts of 8% growth at the start of April.

However, we note that the market's downward EPS revision was predominantly driven by the resources sectors (particularly energy), which are  exposed to slowing global economic activity, although sectors including IT, Discretionary, Utilities and Financials have also contributed to lower EPS revisions.

Key results from the Focus Portfolio over the last month have included ResMed (3Q25), Westpac (1H25), ANZ (1H25), Macquarie Group (FY25), Aristocrat Leisure (1H25), Xero (FY25) and TechnologyOne (1H25). Pleasingly, the Focus Portfolio has experienced no thesis breaks over the course of this out-of-cycle reporting season. This report provides a detailed view of Aristocrat and Xero’s 1H25 and FY25 results, with both companies still core holdings of the Focus Portfolio. 

Figure 1: ASX 200 FY26 EPS growth expectations have been revised down following ‘Liberation Day'...
Figure 2: …Although much of this was driven by resources sector downgrades as due to concerns of a slowdown
Figure 3: Most companies that reported out of season have seen downward revisions due to macro or company-specific factors, although there were a few standouts
 
 

Aristocrat Leisure: Disappointed but Poised for a Stronger Second Half

Aristocrat Leisure is held in the Focus Portfolio at a weight of 4%

Aristocrat Leisure’s (ALL) 1H25 result fell short of consensus expectations, resulting in the stock trading -11% lower on the day (it has since partially recovered). Notably, ALL generated NPATA of $733m (+6% YoY), meaningfully below consensus of $811m. The key drivers of the miss were a weaker-than-expected fee-per-day outcome in North American Gaming Operations, and softer outright EGM (electronic gaming machine) sales in Rest of World (RoW) markets.

Figure 4: Aristocrat 1H25 key numbers
A$m 1H25a 1H25e %YoY vs consensus
Revenue 3053 3193 9% -4%
EITA 1052 1122 11% -6%
NPATA 733 811 6% -10%
EPSA 116 129 7% -10%

Source: Visible Alpha, Aristocrat Leisure company filings, Wilsons Advisory.

Consensus was too high – Aristocrat previously flagged a 2H25 skew

While ALL fell short of expectations, this was partially a consensus issue, given ALL already flagged at its AGM that: 1) 1H25 fee per day would fall YoY; 2) NPATA growth would be 2H-skewed; and 3) the Plarium sale would be dilutive to earnings in the near-term. Looking forward, we remain confident  ALL’s growth will accelerate in 2H25, given:

  • Outright sales will accelerate after new product launches – Outright EGM sales in ROW were softer due to the timing of new product releases, with customers holding off on purchases before highly anticipated launches in 2H25 (Baron Upright cabinet, new titles like Phoenix Link). Given the strong early demand for these releases in North America, we have confidence this will translate to an acceleration of outright sales in the ROW next half.  
  • Fee per day decline to reverse – ALL’s North American Gaming Operations fee per day fell by -5% YoY to US$52.73, driven primarily by product/channel mix shifts (i.e. growth in lower fee products/channels e.g. Class II), as well as some weakness in gross gaming revenue (GGR). However, ALL has retained its market-leading fee per day and expects these factors to begin to unwind in 2H25, supported by new product releases.
Figure 5: Aristocrat’s fee per day is expected to improve from 2H25

Medium-term fundamentals unchanged

Leaving aside the noise around the 1H25 result, our view on the key drivers to ALL’s medium/long-term earnings growth outlook remains unchanged, including: 

  • Continued land-based gaming share gains – a key highlight was the continued strength of its North American Gaming Operations business, which posted yet another half of market share gains, underpinned by its market-leading games due to industry-leading design and development investments. 
  • iGaming opportunity – we have confidence that Aristocrat Interactive will achieve its US$1bn revenue target by FY29, given the company’s existing industry/customer relationships, its track record of successfully scaling new verticals (e.g. Pixel United), and its vast portfolio of existing best-in-class IP that will be leveraged.
  • M&A firepower – ALL’s balance sheet is very strong following its Plarium sale (net debt / EBITDA of just 0.2x), allowing it to pursue strategic/accretive acquisitions.
Figure 6: Aristocrat continued its run of land-based market share gains in 1H25
Figure 7: US land-based gaming revenues have been relatively resilient through economic cycles…
Figure 8: …Additionally, Aristocrat has a strong track-record of growing above-system

The risk/reward is attractive post-pullback

With ALL’s fundamentals unchanged, its valuation is attractive at a 12 month forward PE of 22.5x, given its EPS CAGR from FY25-30 is expected to be ~11%. Furthermore, it operates in an attractive industry, where its core exposure, US land-based gaming, has steadily and consistently grown its GGR with a five-year CAGR of 7.6%, with ALL able to grow above-system due to consistent market share gains. The industry is also incredibly resilient, having only three years of negative growth in the past three decades.

 
 

Xero: Multiple Levers to Drive Growth

Xero is held in the Focus Portfolio at a weight of 3%

Xero’s (XRO) FY25 results highlighted the continued strength of its underlying drivers, reassuring the market that it can continue growing its subscriber base while raising prices. Furthermore, the result demonstrated that management is astutely balancing out revenue growth and free cash flow generation. Overall, this result gives us further conviction in Xero’s ability to pull the multiple levers it has available to maintain strong growth in an industry that continues to benefit from cloud adoption and digital transformation tailwinds. 

Figure 9: Xero FY25 key numbers – Rule of 40 and ARPU the highlights
FY25a FY25e vs consensus
Revenue (NZ$m) 2103 2105 -0.1%
Adjusted EBITDA ((NZ$m) 641 653 -1.9%
Opex/sales 72.1% 71.1% 1.0%
Total subscribers (k) 4414 4414.7 0.0%
Net adds (k) 254 262.4 -3.2%
Net adds (ex long-idle removals) (k) 414
ARPU (NZ$m) 45.08 41.53 8.5%
Rule of 40 (cc sales growth + FCF margin) 44.1% 39.7% 4.4%

Source: Visible Alpha, Xero company filings, Wilsons Advisory.

Xero continues to flex its pricing power

In recent years, Xero has exercised its pricing levers to great effect, which was demonstrated again in this result. Its average revenue per user (ARPU) of NZ$45.08 was well above expectations ($41.53). However, consensus forecasts remain conservative, despite multiple upgrades. To illustrate ‘the Street’s’ tendency to significantly underestimate Xero’s ARPU, FY28 ARPU consensus a year ago is below FY25’s actual ARPU. 

However, before recent years, the company had left its pricing levers idle for a long period of time, letting volume drive its growth, so it retains a long runway for price rises. This is demonstrated by its peer Intuit, which has a considerably higher ARPU after consistently raising prices. This is a pathway Xero can follow and is underappreciated by consensus.

Figure 10: Xero’s recently strong ARPU growth has resulted in consensus upgrades, although risks are still skewed to the upside as it still well below Intuit’s

Pricing isn’t affecting volumes

Crucially, this result allayed concerns that Xero would become over reliant on pricing, as subscriber growth held up well. Stripping out the effect of removing long-idle subscribers, underlying growth was +10% vs the pcp, which is roughly in line with FY24 growth, a strong result. Consequently, we learned that pricing is not a shift in focus (from volume growth), but rather an additional focus, with volume growth still a key pillar of the growth story.

Figure 11: Subscriber growth remains strong despite price rises
Figure 12: Churn remains lower than pre-pandemic levels despite price rises

Rule of 40 – the benchmark or just a new baseline? 

Xero continues to surprise to the upside on the Rule of 40 (R40) metric (constant currency revenue growth + FCF margin of at least 40%), which it reached in FY24, years earlier than expected. Xero achieved 44.1% in FY25, significantly beating consensus of 39.7% (FY25e R40 was just 31% a year ago). This was driven by strong FCF margins, which demonstrates that Xero can maintain strong revenue growth while expanding profitability and without overspending on software development capex.

We believe there is a strong case for consensus upgrades. Forecasts of a return back down to 40% is too conservative, as Xero has the ability to expand its margin while maintaining strong revenue growth.

Figure 13: Consensus continues to underestimate Xero’s Rule of 40, where risks continue to remain skewed to the upside

Higher opex isn’t a major concern and remains as a key lever

The key drawback to the otherwise-strong result was higher-than-expected operating costs, contributing to its earnings miss. A part of this was due to the timing of an increase in share-based compensation, which is largely non-recurring. However, it partially reflects Xero’s investment in driving subscriber growth, which we are comfortable with. This is because at any point in time, Xero has the ability to shift its focus and move its cost base much lower. Figure 14 illustrates the large step-down in P/E if opex/sales (currently ~72%) was (hypothetically) reduced to move in line with mature peers (45.4%).

Figure 14: If Xero pulls its cost levers to be in line with mature peers, its forward P/E can be drastically reduced to very attractive levels

Xero is well placed to grow and expand profitability

In summary, we expect strong growth to continue to be driven by robust subscriber growth (HSD to LDD) and consistently increasing ARPU, against the backdrop of attractive industry conditions. Despite the currently high forward multiple, Figure 14 demonstrates the underlying value that is able to be generated and is overall still attractive for a company that is expected to grow its EPS by 37.5% p.a. (CAGR) to FY30, with the potential for upgrades.

 

Retaining Conviction in Our Positioning

In summary, with most of our holdings having reported in this out of season reporting period, our conviction in our portfolio holdings remain unchanged despite the mixed results. Xero’s result left us with more conviction in its ability to continue to pull its growth levers, while Aristocrat’s disappointing figures are a speed bump, with indications pointing to a re-acceleration of growth in the second half.

Figure 15: Out of cycle reporting summary
Company Name Ticker Portfolio Weight Period Reporting date Result commentary
Resmed RMD 4.0% 3Q25 24-Apr

ResMed's Q325 operating result was broadly in line with expectations. Revenue grew +9%, while gross margins expanded +138bps to 59.9% (+ 44bps vs consensus), driving core EPS growth of +11%. Investors are likely to be encouraged by ongoing strength in patient starts and resupply which show no sign of any GLP-1 headwinds to CPAP demand.

Westpac WBC 5.5% 1H25 5-May

WBC posted a mixed result, with earnings, dividends and NIM (1.88%) slightly short of expectations, while its CET1 (12.2%) and bad debts were better than expected. In addition, opex was in line with expectations, increasing +2.7% HoH due to higher head count and spending on its IT overhaul.

ANZ ANZ 8.0% 1H25 8-May

ANZ's result was solid, with cash NPAT (+12.4% HoH) and dividends in line with consensus. Operating costs were a highlight, increasing +3.9%, below expectations. Credit impairment charges were also lower than expected. Disappointingly, ANZ's NIM (1.56%) and CET1 (11.8%) was slightly below expectations.

Macquarie Group MQG 4.0% FY25 9-May

Given that MQG's 3Q25 update implied it was well behind the run rate to meet full-year consensus, it was impressive that FY25 earnings ended up meeting consensus. This was driven by MAM, aided by asset sales being realised in the last quarter. Pleasingly, management reiterated FY26 guidance for NPAT to grow +13%.

Aristocrat Leisure ALL 4.0% 1H25 14-May

ALL missed expectations across the board, although consensus was too high after management flagged a second half skew. ROW outright sales and North American Gaming fee-per-day disappointed, although this should turn around the release of new premium products.

Xero XRO 3.0% FY25 15-May

XRO posted a strong result, demonstrating it's able to raise prices without stifling volume growth. Although its opex was higher-than-expected, this was largely due to one-off share-based comp payments.

TechnologyOne TNE 2.0% 1H25 20-May

TNE's result was very strong. Revenue increased +19% to $286m (vs consensus $278m) and PBT increased +33% to $81.9m (vs consensus $77.2m). Management upgraded guidance PBT guidance to +13-17% (from +12-16%), which still looks conservative, given it would only need +6% 2H growth to reach the top end of guidance.

James Hardie JHX 4.0% FY25 21-May Yet to report.
Collins Foods CKF 3.0% FY25 23-Jun

Yet to report.

Source: Wilsons Advisory.

  • Share This Article

Written by

Greg Burke, Equity Strategist

Greg is an Equity Strategist in the Investment Strategy team at Wilsons Advisory. He is the lead portfolio manager of the Wilsons Advisory Australian Equity Focus Portfolio and is responsible for the ongoing management of the Global Equity Opportunities List.

Disclaimer and Disclosures

About Wilsons Advisory: Wilsons Advisory is a financial advisory firm focused on delivering strategic and investment advice for people with ambition – whether they be a private investor, corporate, fund manager or global institution. Its client-first, whole of firm approach allows Wilsons Advisory to partner with clients for the long-term and provide the wide range of financial and advisory services they may require throughout their financial future. Wilsons Advisory is staff-owned and has offices across Australia.

Disclaimer: This communication has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665; AFSL 238375) and/or Wilsons Corporate Finance Limited (ACN 057 547 323; AFSL 238383) (collectively “Wilsons Advisory”). It is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this communication. To the extent that any information prepared by Wilsons Advisory contains a financial product advice, it is general advice only and has been prepared by Wilsons Advisory without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives, financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document before making any decision to acquire or dispose of a financial product. Wilsons Advisory's Financial Services Guide is available at wilsonsadvisory.com.au/disclosures.

All investments carry risk. Different investment strategies can carry different levels of risk, depending on the assets that make up that strategy. The value of investments and the level of returns will vary. Future returns may differ from past returns and past performance is not a reliable guide to future performance. On that basis, any advice should not be relied on to make any investment decisions without first consulting with your financial adviser. If you do not currently have an adviser, please contact us and we would be happy to connect you with a Wilsons Advisory representative.

To the extent that any specific documents or products are referred to, please also ensure that you obtain the relevant disclosure documents such as Product Disclosure Statement(s), Prospectus(es) and Investment Program(s) before considering any related investments.

Wilsons Advisory and their associates may have received and may continue to receive fees from any company or companies referred to in this communication (the “Companies”) in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons Advisory disclosures at www.wilsonsadvisory.com.au/disclosures.

Related articles